Shared practical advice on the management of toxicities associated with antibody drug conjugate therapy in both the breast cancer and GI cancer settings.
Patients fear being a "guinea pig" or receiving a placebo, healthcare providers do not have time to keep up with all of the clinical trial information or talk with patients in depth, conducting clinical trials is very expensive for healthcare systems, and funding continues to decline for research
A multidisciplinary care team is needed when treating patients who are given a combination of chemotherapy and immunotherapy.
Oncology nurses can lead the way in efforts to protect the next generation from this type of cancer if they know the facts about HPV vaccination for both girls and boys
Carla Remondini, MSN, RN-BC, AGCNS-BC, OCN, of Scripps Mercy Hospital, discuss how language, particularly the use of military metaphors, can affect a patient's ability to cope with cancer.
A majority of adult patients with β-thalassemia who require regular red blood cell (RBC) transfusions experienced clinically meaningful and durable transfusion burden reduction associated with luspatercept (Reblozyl) in the phase III BELIEVE trial.
There is so much important and actionable clinical data found in clinicians' notes in electronic medical records (EMRs).
I’m sure we can all agree that we’d like to provide the best care possible to our patients each and every day.
As more studies link aggressive end-of-life oncology care to problems such as suboptimal cost and quality outcomes, experts are increasingly proposing earlier, more comprehensive palliative care interventions.
Canhua Xiao, PhD, RN, postdoctoral fellow, Nell Hodgson Woodruff School of Nursing, Emory University, discusses ways to manage Intensity-Modulated Radiation Therapy (IMRT)- related fatigue.
While controversial, advances in understanding how prostate cancer treatments impact the physiology of erections have led to increased interest in penile rehabilitation interventions for these patients.
Family caregiver satisfaction with end-of-life care is key to better understanding patient experiences.
Karen Lee explains why it is important for patients to understand immunotherapy and how nurses can help them in patients education.
Dense breast tissue can make tumors more difficult to spot in mammograms. And extremely dense tissue may be an independent risk factor for developing breast cancer.
Roger Lo, MD, PhD, UCLA Jonsson Comprehensive Cancer Center, discusses the evolution of metastatic melanoma during therapy.
Brian Loew, CEO, Inspire, explains how oncology nurses can benefit from online cancer patient communities
While PARP inhibitors have played a large part in improving progression-free survival (PFS) in patients with ovarian cancer, long-term use of these agents often leads to resistance that are often quite challenging to overcome, according to Gottfried E. Konecny, MD.
There are multiple key players, including oncology nurses, in the treatment of patients with myelodysplastic syndrome.
Even with the rise in male caregivers for patients with cancer, little research has been done to ensure there is effective support for both male and female caregivers. Several researchers have reported that men experience fewer negative aspects of caregiving (such as depression) compared with female caregivers.
Innovative models for palliative care delivery and primary palliative care training are springing up to address the mismatch between the demand for this care and the capacity to deliver it.
Karley Trautman, DNP, ANP-BC, of University of Colorado Hospital explains how a quality improvement program helped them to reduce venous thromboembolism (VTE).
Melissa L. Bondy, PhD, MS, associate director for cancer prevention and population sciences at Baylor College of Medicine, discusses the importance of finding genetic mutations that can cause cancers such as glioma.
Several breast cancer treatment programs are reporting substantially less clinical lymphedema, particularly among patients at high risk after axillary dissection, radiation, or taxane-based chemotherapy, crediting their use of preclinical detection using bioimpedance spectroscopy (BIS).
Rebecca Lehto, PhD, RN, OCN, assistant professor, College of Nursing, Michigan State University, discusses holistically treating patients with cancer.
Consider the family's feelings and check workplace policies when determining how best to share condolences and cope with your grief.
Michelle Gervino, RN, BSN, OCN, John Theurer Cancer Center, discusses side effects that patients with hematologic malignancies may experience during treatment
Sharon L. Bober, PhD, director, Sexual Health Program, Dana-Farber Cancer Institute, discusses how changes in sexual health differ with various treatments.
Despite many exciting advances in recent years, there are still aspects of melanoma treatment that need to be further studied and understood, said Grace Cherry, NP, a nurse practitioner at UCLA Health.